Guanine nucleotides modulate the affinity of antagonists at beta-adrenergic receptors.
Investigation of the properties of the binding of the radiolabelled antagonists (125I)-iodohydroxybenzylpindolol, (125I)-iodopindolol, and (125I)-iodocyanopindolol to beta-adrenergic receptors of L6 myoblast membranes revealed that guanine nucleotides caused a 2 to 4.5 fold increase in the apparent affinity of these antagonists. No significant effects of GTP were observed on the density of binding sites determined with each radioligand. GTP, GDP, and GMPPNP were of similar high affinity in producing this effect, while GMP was much less potent, and ATP was without effect. Under similar assay conditions GTP reduced the apparent binding affinity of the agonist isoproterenol for the beta-adrenergic receptors of L6 cells. The results indicate that, contrary to previous observations, guanine nucleotides affect not only the interactions of agonists with beta-adrenergic receptors, but also the interaction of antagonists with these adenylate cyclase-linked receptors.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D001667:Binding, Competitive; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D006150:Guanine Nucleotides / Q000502:physiology*; D006160:Guanosine Triphosphate / Q000378:metabolism; D020120:Iodocyanopindolol; D007700:Kinetics; D009132:Muscles / Q000166:cytology; D010869:Pindolol / Q000031:analogs & derivatives / Q000494:pharmacology; D011869:Radioligand Assay
D000319:Adrenergic beta-Antagonists; D006150:Guanine Nucleotides; C011878:iodohydroxybenzylpindolol; C029247:3-iodopindolol; D020120:Iodocyanopindolol; D006160:Guanosine Triphosphate; D010869:Pindolol; D000242:Cyclic AMP